Your browser is no longer supported. Please, upgrade your browser.
Settings
PRTO Proteon Therapeutics, Inc. daily Stock Chart
PRTO [NASD]
Proteon Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.19 Insider Own1.10% Shs Outstand19.10M Perf Week7.55%
Market Cap57.11M Forward P/E- EPS next Y-0.89 Insider Trans0.00% Shs Float17.36M Perf Month16.34%
Income-21.00M PEG- EPS next Q-0.26 Inst Own70.40% Short Float2.74% Perf Quarter81.21%
Sales- P/S- EPS this Y-23.40% Inst Trans0.16% Short Ratio6.56 Perf Half Y32.89%
Book/sh0.19 P/B15.74 EPS next Y21.20% ROA-61.00% Target Price5.50 Perf Year42.38%
Cash/sh1.37 P/C2.18 EPS next 5Y- ROE-293.70% 52W Range1.50 - 3.10 Perf YTD31.72%
Dividend- P/FCF- EPS past 5Y-16.20% ROI- 52W High-3.55% Beta0.80
Dividend %- Quick Ratio10.70 Sales past 5Y- Gross Margin- 52W Low99.33% ATR0.15
Employees19 Current Ratio10.70 Sales Q/Q- Oper. Margin- RSI (14)71.09 Volatility5.83% 6.13%
OptionableNo Debt/Eq0.00 EPS Q/Q76.70% Profit Margin- Rel Volume2.96 Prev Close2.97
ShortableYes LT Debt/Eq0.00 EarningsMar 13 BMO Payout- Avg Volume72.38K Price2.99
Recom2.40 SMA2010.60% SMA5027.87% SMA20036.66% Volume214,558 Change0.67%
Feb-11-19Upgrade JMP Securities Mkt Perform → Mkt Outperform $9
Oct-30-18Initiated Maxim Group Buy $5
Mar-17-17Downgrade H.C. Wainwright Buy → Neutral $18 → $3
Dec-14-16Reiterated Maxim Group Buy $19 → $6
Dec-14-16Downgrade Stifel Buy → Hold $19 → $3
Dec-14-16Downgrade Raymond James Strong Buy → Mkt Perform
Dec-14-16Downgrade JMP Securities Mkt Outperform → Mkt Perform
Dec-13-16Downgrade Robert W. Baird Outperform → Neutral $20 → $3
Nov-10-16Initiated Maxim Group Buy $19
Oct-26-16Upgrade Raymond James Outperform → Strong Buy
Sep-22-16Initiated H.C. Wainwright Buy $18
Apr-14-16Initiated Robert W. Baird Outperform $20
Mar-15-16Reiterated Stifel Buy $20 → $19
Nov-11-15Initiated Raymond James Outperform
Nov-17-14Initiated Stifel Buy $17
Nov-17-14Initiated Robert W. Baird Outperform $15
Feb-12-19 09:25AM  4 Healthcare Stocks Looking To Set February Highs ACCESSWIRE
Jan-24-19 08:00AM  Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease GlobeNewswire -5.70%
Dec-20-18 10:49AM  Does The Proteon Therapeutics, Inc. (NASDAQ:PRTO) Share Price Fall With The Market? Simply Wall St.
Nov-16-18 07:35AM  New Research Coverage Highlights Yum! Brands, TELUS, Unifi, Proteon Therapeutics, Sabine Royalty Trust, and Algonquin Power & Utilities Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-08-18 07:45AM  Proteon Therapeutics to Present at the Stifel 2018 Healthcare Conference November 13th GlobeNewswire +5.12%
Nov-07-18 10:03AM  Proteon Therapeutics: 3Q Earnings Snapshot Associated Press
08:00AM  Proteon Therapeutics Announces Third Quarter 2018 Financial Results GlobeNewswire
Sep-17-18 03:10PM  Is Proteon Therapeutics Inc (NASDAQ:PRTO) A Strong Healthcare Bet? Simply Wall St.
Aug-07-18 08:11AM  Proteon Therapeutics: 2Q Earnings Snapshot Associated Press
08:00AM  Proteon Therapeutics Announces Second Quarter 2018 Financial Results GlobeNewswire
Jun-14-18 08:00AM  Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21st GlobeNewswire
May-15-18 07:07PM  Proteon Therapeutics Incs (NASDAQ:PRTO) Earnings Dropped -27.47%, How Did It Fare Against The Industry? Simply Wall St.
May-10-18 07:05AM  Blog Exposure - Proteon Extended Long-term Contract with Lonza for Commercial Supply of Vonapanitase's Active Pharmaceutical Ingredient ACCESSWIRE
May-09-18 08:24AM  Proteon Therapeutics: 1Q Earnings Snapshot Associated Press
08:10AM  Proteon Therapeutics Announces First Quarter 2018 Financial Results GlobeNewswire
May-08-18 07:00AM  Proteon Therapeutics and Lonza Extend Manufacturing Agreement for Commercial Supply GlobeNewswire
Mar-14-18 08:06AM  Proteon Therapeutics Inc (NASDAQ:PRTO): Are Analysts Optimistic? Simply Wall St.
08:00AM  Proteon Therapeutics Announces Fourth Quarter and Full-Year 2017 Financial Results GlobeNewswire
Mar-06-18 04:45PM  Proteon Therapeutics to Present at Two Upcoming Investor Conferences GlobeNewswire
Mar-05-18 05:00PM  Proteon Therapeutics Completes Enrollment in PATENCY-2, Phase 3 Clinical Trial of Investigational Vonapanitase GlobeNewswire
Nov-08-17 08:00AM  Proteon Therapeutics to Present at the Stifel 2017 Healthcare Conference November 15th GlobeNewswire -11.90%
Nov-07-17 08:29AM  Proteon Therapeutics reports 3Q loss Associated Press
08:00AM  Proteon Therapeutics Announces Third Quarter 2017 Financial Results GlobeNewswire
Sep-05-17 07:45AM  Proteon Therapeutics to Present at the Baird 2017 Global Healthcare Conference September 7, 2017 GlobeNewswire
Aug-07-17 07:50PM  Proteon Therapeutics reports 2Q loss Associated Press +8.00%
05:00PM  Proteon Therapeutics Announces Second Quarter 2017 Financial Results GlobeNewswire
Aug-02-17 07:30PM  Proteon Therapeutics Announces Closing of $22 Million Convertible Preferred Stock Financing GlobeNewswire -5.45%
Jun-22-17 09:32AM  Proteon Therapeutics Announces $22.0 Million Private Placement GlobeNewswire +11.54%
Jun-15-17 08:00AM  Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21st GlobeNewswire
May-10-17 08:08AM  Proteon Therapeutics reports 1Q loss Associated Press +23.08%
08:00AM  Proteon Therapeutics Announces First Quarter 2017 Financial Results GlobeNewswire
07:30AM  Proteon Therapeutics Receives FDA Breakthrough Therapy Designation for Vonapanitase GlobeNewswire
May-02-17 04:40PM  Proteon Therapeutics Announces Increase to Enrollment of Ongoing Phase 3 PATENCY-2 Clinical Trial GlobeNewswire
May-01-17 08:00AM  Proteon Therapeutics to Present at the Deutsche Bank 42nd Annual Health Care Conference May 4th GlobeNewswire
Apr-05-17 08:01PM  Lifshitz & Miller LLP Announces Investigation of BRF S.A., Innoviva, Inc., Panera Bread Company, PRA Group, Inc., Proteon Therapeutics, Inc., tronc, Inc. and Vuzix Corporation PR Newswire
Mar-23-17 04:41PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Proteon Therapeutics, Inc. Business Wire
Mar-22-17 01:04PM  PROTEON THERAPEUTICS INC Financials
06:04AM  PROTEON THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-17-17 09:20AM  Proteon CEO: New trial could be a path to market at bizjournals.com
09:20AM  Proteon CEO: New trial could be a path to market American City Business Journals
07:55AM  Proteon Therapeutics to Present at the Oppenheimer 27th Annual Healthcare Conference March 22nd GlobeNewswire
07:05AM  Proteon Therapeutics downgraded by H.C. Wainwright
Mar-16-17 08:01AM  Proteon Therapeutics reports 4Q loss Associated Press
08:00AM  Proteon Therapeutics Inc Conference Call to Discuss Clinical Trial Update for PATENCY-2 scheduled for 8:00 am ET today
07:16AM  PROTEON THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
07:15AM  Proteon Therapeutics Announces Full-Year 2016 Financial Results and Changes to the Ongoing Phase 3 PATENCY-2 Clinical Trial GlobeNewswire
07:04AM  PROTEON THERAPEUTICS INC Files SEC form 10-K, Annual Report
Feb-06-17 05:00PM  Proteon Therapeutics Announces Two Presentations at the American Society of Diagnostic and Interventional Nephrology Meeting GlobeNewswire
Jan-05-17 01:37PM  These 5 Stocks Under $10 Could Make You a Lot of Money TheStreet.com
Dec-16-16 08:51PM  How ProQR Therapeutics NV (PRQR) Stacks Up Against Its Peers at Insider Monkey
Dec-14-16 01:30PM  Failure in late clinical trial pummels Proteon Therapeutics stock at bizjournals.com
01:30PM  Failure in late clinical trial pummels Proteon Therapeutics stock American City Business Journals
07:39AM  Proteon Slips to 52-Week Low on Kidney Disease Study Data Zacks
Dec-13-16 11:25AM  Proteon Therapeutics Craters on Missed Late-Stage Results
09:34AM  Waltham biotech's shares tank after kidney disease drug flunks trial at bizjournals.com
08:30AM  Proteon Therapeutics Inc Conference Call to Discuss Top-Line Data from Phase 3 PATENCY-1 Clinical Trial scheduled for 8:30 am ET today
07:54AM  Proteon Therapeutics' stock plummets after failed trial of kidney disease treatment at MarketWatch
07:15AM  Proteon Therapeutics kidney drug fails key study
07:01AM  PROTEON THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
07:00AM  Proteon Therapeutics Announces Top-Line Data from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with CKD GlobeNewswire
Nov-29-16 12:02PM  Proteon Therapeutics, Inc. :PRTO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016
Nov-10-16 08:00AM  Proteon Therapeutics Announces First Patient Dosed in Phase 1 Study Evaluating Vonapanitase for the Treatment of Peripheral Artery Disease Below the Knee GlobeNewswire
Nov-09-16 04:35PM  Proteon Therapeutics to Participate in Two Upcoming Investor Conferences GlobeNewswire
Nov-07-16 08:06AM  Proteon Therapeutics reports 3Q loss
08:01AM  PROTEON THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
08:00AM  Proteon Therapeutics Announces Third Quarter 2016 Financial Results GlobeNewswire
Oct-25-16 08:00AM  Proteon Therapeutics Announces Overview of Phase 1 Clinical Program of Investigational Vonapanitase in Peripheral Artery Disease to be Presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT) Conference GlobeNewswire
Oct-20-16 08:06AM  PROTEON THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
08:00AM  Proteon Therapeutics Appoints Paul Hastings Chairman of Its Board of Directors GlobeNewswire
Sep-01-16 08:00AM  Proteon Therapeutics to Present at Two Upcoming Investor Conferences GlobeNewswire
Aug-08-16 08:09AM  Proteon Therapeutics reports 2Q loss
08:01AM  PROTEON THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
08:00AM  Proteon Therapeutics Announces Second Quarter 2016 Financial Results GlobeNewswire
Jun-26-16 09:31AM  7 Stocks Under $10 to Trade for Big Post-Brexit Gains
Jun-24-16 08:45AM  Proteon Therapeutics (PRTO) in Focus: Stock Gains 6.4%
Jun-15-16 08:00AM  Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 22nd GlobeNewswire
Jun-13-16 08:01AM  PROTEON THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-08-16 06:07PM  Proteon Therapeutics, Inc. :PRTO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016
May-09-16 08:28AM  Proteon Therapeutics reports 1Q loss
08:02AM  PROTEON THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
08:00AM  Proteon Therapeutics Announces First Quarter 2016 Financial Results GlobeNewswire
Apr-28-16 07:00AM  Proteon Therapeutics Announces Survey Findings Demonstrating Impact of Vascular Access Failure on Hemodialysis Patients GlobeNewswire
Apr-13-16 08:00AM  Proteon Therapeutics Announces Publication in the Journal of Cardiovascular Pharmacology of Promising Nonclinical Results for Vonapanitase in Peripheral Artery Disease GlobeNewswire
Mar-14-16 08:57AM  Proteon Therapeutics reports 4Q loss
08:31AM  PROTEON THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
08:30AM  Proteon Therapeutics Announces Fourth Quarter and Full-Year 2015 Financial Results GlobeNewswire
Mar-02-16 05:00PM  Proteon Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference on March 8th GlobeNewswire
Feb-02-16 08:00AM  Proteon Therapeutics to Present at the 2016 BIO CEO & Investor Conference February 8th GlobeNewswire
Jan-22-16 08:31AM  PROTEON THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Dec-07-15 08:10AM  How it all Plays Out - Research on Lawson Products, PAM Transportation Services, Hallmark Financial Services and Proteon Therapeutics Accesswire
Dec-02-15 08:00AM  Proteon Therapeutics to Present at the Oppenheimer 26th Annual Healthcare Conference December 9th GlobeNewswire
Nov-30-15 10:43AM  Is InVitae Corp (NVTA) Going to Burn These Hedge Funds? at Insider Monkey
Nov-27-15 08:05AM  Trading Ahead of Upcoming Developments - Research on Lawson Products, PAM Transportation Services, Hallmark Financial Services and Proteon Therapeutics Accesswire
Nov-13-15 07:45AM  Proteon Therapeutics to Present at the Stifel 2015 Healthcare Conference on November 17th GlobeNewswire
Nov-12-15 04:17PM  PROTEON THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh
09:25AM  Proteon Therapeutics reports 3Q loss
08:00AM  Proteon Therapeutics Announces Third Quarter 2015 Financial Results GlobeNewswire
Nov-09-15 11:58AM  Proteon Therapeutics to Host Research and Development Day on November 20, 2015 GlobeNewswire
Nov-02-15 04:17PM  PROTEON THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
04:15PM  Proteon Therapeutics Completes Enrollment in PATENCY-1, First Phase 3 Clinical Study of Investigational Vonapanitase GlobeNewswire
Proteon Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease. Its lead product candidate is vonapanitase, an investigational drug intended to improve hemodialysis vascular access outcomes. The company develops vonapanitase, a recombinant human elastase, which has completed Phase II and Phase III clinical trials for patients with chronic kidney disease. It is also evaluating vonapanitase in a Phase I clinical trial in patients with peripheral artery disease. The company was founded in 2001 and is based in Waltham, Massachusetts.